# Adzenys XR-ODT

NDC: 70165-015
Generic name: Amphetamine
Labeler / Manufacturer: Neos Therapeutics Brands, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20160216

FDA application: NDA204326

## Active ingredients

- AMPHETAMINE: 9.4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70165-015"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70165-015
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c1179269-00b5-48ea-972d-31e614e99b7e